"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC. Zheng MM, Wu YL. J Thorac Oncol 2024;19:1146-1150.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zheng MM, Wu YL. "Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC. J Thorac Oncol 2024;19:1146-1150.
PMID: 39112001